Beta-Oxidation

Overview

Beta-oxidation is the catabolic process by which fatty acid molecules are broken down in the mitochondria to generate acetyl-CoA, NADH, and FADH2. Named for the oxidation that occurs at the beta-carbon of the fatty acid chain, this pathway is the primary mechanism by which the body extracts energy from stored fat. The acetyl-CoA produced enters the Krebs cycle for further oxidation, while NADH and FADH2 feed into oxidative phosphorylation for ATP generation.

Fat is the most energy-dense macronutrient, and beta-oxidation of a single palmitate molecule (16 carbons) yields approximately 106 ATP — far more than the 30-32 ATP from glucose. This makes beta-oxidation critical during fasting, prolonged exercise, and any physiological state requiring sustained energy output.

How It Works

Fatty Acid Activation and Transport

Before entering beta-oxidation, free fatty acids must be activated and transported into the mitochondrial matrix:

1. Activation — Fatty acyl-CoA synthetase on the outer mitochondrial membrane converts the fatty acid to fatty acyl-CoA, consuming 2 ATP equivalents
2. Carnitine shuttle — Long-chain fatty acyl-CoA cannot cross the inner membrane directly. CPT1 (carnitine palmitoyltransferase 1) on the outer membrane converts fatty acyl-CoA to fatty acylcarnitine. Carnitine-acylcarnitine translocase shuttles it across. CPT2 on the inner membrane regenerates fatty acyl-CoA in the matrix

CPT1 is the rate-limiting step of beta-oxidation and is inhibited by malonyl-CoA (an intermediate of fatty acid synthesis), ensuring that synthesis and oxidation do not occur simultaneously.

The Beta-Oxidation Spiral

Each cycle of beta-oxidation removes a two-carbon unit from the fatty acid chain through four enzymatic steps:

1. Acyl-CoA dehydrogenase — Introduces a double bond between alpha and beta carbons (produces FADH2)
2. Enoyl-CoA hydratase — Adds water across the double bond
3. 3-Hydroxyacyl-CoA dehydrogenase — Oxidizes the beta-hydroxyl group to a ketone (produces NADH)
4. Thiolase — Cleaves the two-carbon acetyl-CoA, producing a shortened fatty acyl-CoA

A 16-carbon palmitate requires seven cycles, yielding 8 acetyl-CoA, 7 NADH, and 7 FADH2.

Regulation

Beta-oxidation is stimulated during fasting, exercise, and catecholamine release, when hormone-sensitive lipase liberates fatty acids from adipose tissue. Growth hormone and glucagon promote lipolysis and fatty acid availability for beta-oxidation, while insulin suppresses lipolysis and favors fatty acid storage.

Key Components

• Carnitine and CPT1/CPT2 — The transport system for long-chain fatty acids into mitochondria
• Malonyl-CoA — Key inhibitor of CPT1 linking fatty acid synthesis and oxidation
• Acyl-CoA dehydrogenase family — Enzymes specific to short-, medium-, long-, and very-long-chain fatty acids
• Acetyl-CoA — The two-carbon product feeding the Krebs cycle
• Hormone-sensitive lipase — The adipose enzyme releasing fatty acids for oxidation

Peptide Connections

Several peptides influence beta-oxidation through hormonal regulation of lipolysis and fat metabolism:

AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) specifically designed to enhance fat metabolism. AOD-9604 stimulates lipolysis in adipose tissue and has been shown to increase fatty acid availability for beta-oxidation without the diabetogenic effects of full-length growth hormone. Research has demonstrated fat loss in obese subjects without significant effects on IGF-1 levels or glucose homeostasis.

The growth hormone axis is a primary endocrine driver of beta-oxidation. Growth hormone released from the anterior pituitary stimulates lipolysis in adipose tissue, increasing free fatty acid flux to muscles, liver, and other tissues for beta-oxidation. Peptides that stimulate GH release — including ipamorelin, GHRP-6, sermorelin, and tesamorelin — indirectly promote beta-oxidation by elevating endogenous GH levels.

Glucagon promotes beta-oxidation in the liver by reducing malonyl-CoA levels (through inhibition of acetyl-CoA carboxylase), relieving CPT1 inhibition and allowing increased fatty acid entry into mitochondria. This is why beta-oxidation increases during fasting when the glucagon-to-insulin ratio rises.

MOTS-c influences fat metabolism through AMPK activation. AMPK phosphorylates and inactivates acetyl-CoA carboxylase, reducing malonyl-CoA production and thereby derepressing CPT1 to promote beta-oxidation. This mechanism links mitochondrial signaling peptides to the regulation of fat catabolism.

Clinical Significance

Defects in beta-oxidation enzymes constitute a group of inherited fatty acid oxidation disorders, the most common being medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, which affects approximately 1 in 10,000 newborns. These conditions present with hypoketotic hypoglycemia, lethargy, and potentially fatal metabolic crises during fasting.

Impaired beta-oxidation contributes to lipotoxicity in obesity, metabolic syndrome, and type 2 diabetes, where excess fatty acid supply overwhelms mitochondrial oxidative capacity, leading to accumulation of toxic lipid intermediates such as ceramides and diacylglycerols.

Related Topics

• Krebs Cycle — Receives acetyl-CoA from beta-oxidation for further energy extraction
• Ketogenesis — Converts excess acetyl-CoA from beta-oxidation into ketone bodies
• Lipogenesis — The opposing pathway that synthesizes fatty acids
• Growth Hormone Release — Endocrine driver of lipolysis and beta-oxidation
• AOD-9604 — GH-derived peptide targeting fat metabolism